R&D Department
In order to fulfil our corporate mission of "Better Lives
Through Better Medicine", our R&D Department is advancing
research.
Our
research laboratories use state of the art equipment, the
latest academic information and the sophisticated scientific
techniques to study specific aspects of pharmaceutical
production.
Our
close collaboration with International Universities (e.g.
UK, Germany, Netherlands, U.S.A., Russia, Greece, France,
Spain etc.) and our scientific information centre, are
further guarantees of our ability to deal with advanced
projects.
We also exploit our very good scientific relations with the
international academic community, to perform specific analytical
requirements (mass spectrometry, atomic absorption, etc )
Up to now, we have achieved substantial progress in the
following research areas : Cancer, HIV, Drug Delivery Systems,
Contact Lenses, Diagnostics, Peptides & Lasers.
Joint Research Programs in Progress:
COST of European Union
Title: Multidrug resistance reversal.
Research participants: Institute of Research "Pierre Fabre Medicament",
Medicin General IMTSSA, University & Biocenter, Humboldt University, University
of Turku, Hospital Univeritaire, University of Manchester, HELP S.A.
BIOMED of European Union
Title: Development of a new Respiratory Tract Drug Application Technology for
the treatment of Pulmonary iseases. Research participants: FILT GmbH, G.O.T.
GmbH, HALAS -Germany-, MAX - Delbruck -, University Clinic of Rotterdam, HELP
S.A.
PAVE National
Title: Synthesis of Vanadium complexes for the treatment of malignant tumours
of soft tissues. Research participants: University of Ioannina -Medical and
Chemical Department-, National Center for Scientific Research "Dimokritos",
HELP S.A.